Company intelligence / Profile preview

ANM Adaptive Neuromodulation

Cologne, Nordrhein-Westfalen, Germanypmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

ANM’s acoustic CR neuromodulation has demonstrated efficacy in reducing tinnitus symptoms in approximately 70% of treated patients. Clinical studies confirm safety and effectiveness; over 2,000 patients have been treated across Europe. The RESET study series provided evidence supporting regulatory approvals. The device received CE marking and EU market approval in February 2010; FDA clearance was granted later that year. No pharmacological agents are involved—therapy uses individualized sound stimulation to desynchronize pathological neural activity associated with chronic tonal tinnitus symptoms.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

T30 CR

Commercial

Indications: Tinnitus

Partnerships

Helbling for design transfer/manufacturing supportAcademic collaborations with Research Center JülichUniversity of Cologne

Beyond the preview

Go deeper on ANM Adaptive Neuromodulation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANM Adaptive Neuromodulation.

Explore the full profile